SIRT6 and hepatocellular carcinoma: SIRT6 deacetylates Beclin-1 in hepatocellular carcinoma (HCC) cells and stimulates the autophagic degradation of E-cadherin, which in turn promotes epithelial-mesenchymal transition (EMT) in HCC cells and ultimately increases metastasis in liver cancer [52].